{{Rsnum
|rsid=11886877
|Gene=IL1R2
|Chromosome=2
|position=101994259
|Orientation=plus
|GMAF=0.2319
|Gene_s=IL1R2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.5 | 26.2 | 72.3
| HCB | 0.0 | 36.4 | 63.6
| JPT | 4.5 | 36.4 | 59.1
| YRI | 28.8 | 44.1 | 27.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 36.4 | 63.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24359571
|Title=The impact of genetic variants in inflammatory-related genes on prostate cancer risk among men of African Descent: a case control study
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}